The content of filamentous actin in individual platelets was measured by flow cytometry, using a fluorescent probe specific for filamentous actin (F-actin), 7-nitrobenz-2-oxa-l.3-phallacidin (NBD-phallacidin). NBD-phallacidin binding t o fixed platelets was specific in that either pretreatment of platelets with unlabeled phallacidin or absorption of NBDphallacidin by rabbit skeletal F-actin, but not globular actin (G-actin), resulted in a significant loss in the bound fluorescent probe. Mean NBD-phallacidin binding t o fixed platelets varied with the agonist and paralleled the changes in F-actin reported with the DNAse I inhibition assay. 
measurements of cytosolic free calcium concentration ([Ca"],) by flow cytometry in Indo-1-loaded platelets, ADP's doseresponse for actin polymerization was similar t o that for calcium mobilization. As shown by flow cytometry, a tail population that had a minimal increase in F-actin upon stimulation with ADP or U46619 also contained the platelets with the least forward and right angle light scattering, which are functions of platelet size and shape. When platelets treated with NBD-phallacidin were incubated with S12-murine monoclonal antibody (a marker of agranule secretion detected by phycoerythrin-conjugated antimouse IgG second antibody), phallacidin fluorescence paralleled SI2 binding. Thus, human blood platelets are heterogeneous in regard t o actin polymerization at rest and in association with platelet activation; different degrees of phallacidin binding may identify functionally different platelet populations. o 1992 by The American Society of Hematology.
fibrinogen binding,14 fibrinogen receptor expressi~n,'~ and granule ~ecretion.'~.'~ Recently, we reported that low concentrations of thrombin produce a heterogeneous distribution of elevation of [Ca'+], in platelets and that this is reflected in parallel inhomogeneity in secretion." This finding suggests that heterogeneity in different aspects of platelet activation may be related. To address the question of the possible heterogeneity of F-actin content among individual platelets, we used 7-nitrobenz-2-oxa-l,3-phallacidin (NBDphallacidin) for flow cytometric studies. This probe is a fluorescent derivative of mushroom (Amanita phalloides) toxins and has been successfully used for flow cytometric studies of fixed neutrophiles and other cell^.'^-'^ With measurement of F-actin content in individual platelets by NBD-phallacidin, we confirmed the increase in F-actin content upon platelet stimulation and, further, found that there was heterogeneity in F-actin content among individual platelets. This method, which requires as little as 10 pL of platelet-rich plasma (PRP), may be useful to answer other questions of basic or clinical interests.
MATERIALS AND METHODS
Materials were obtained as follows. NBD-phallacidin and Indo-1 acetoxymethylester (AM) were from Molecular Probes (Eugene, OR); ADP, U46619 (9, ll-dideoxy-9a, lla-methoepoxy prostaglandin F2a), epinephrine, cytochalasin D, phallacidin, aspirin, phycoelythrin (PE)-conjugated antimouse goat antibody, rabbit skeletal actin, and mouse IgG2b (MOPC 141) were from Sigma (St Louis, MO); horse type I collagen was from Hormon-Chemie (Munchen, Germany); glutaraldehyde was from Fisher Scientific (Fairlawn, NJ); green fluorescent standard beads for flow cytometry were from Flow Cytometry Standards (Research Triangle Park, NC); S12 antibody? which reacts with GMP-140 molecule,2' was the kind donation of Dr Rodger P. McEver (University of Oklahoma).
Measurement of NBD-phallacidin binding to individual platelets. was collected to avoid contaminating red cells. In such preparations, fewer than 2% of cells were contaminating red cells, as determined by phase microscopy. PRP was warmed at 37°C for 30 minutes before experiments. Except in experiments with collagen, aspirin (1 mmol/L) was added 30 minutes before platelet agonists. Fifteen seconds before each experiment, 5 mmol/L EDTA was routinely added to prevent aggregation of platelets. An aliquot (10 to 50 pL) of PRP was fixed with freshly prepared 2.5% glutaraldehyde (1.5 mL) in phosphate-buffered saline (PBS; pH 7.4) at 37°C. After fixation (at least 2 hours), platelets were centrifuged (8OOg for 5 minutes) and washed twice in PBS. Fixed platelets (106 cells) were incubated with NBD-phallacidin and resuspended in PBS at a final concentration of 3.3 pmol/L. In preliminary experiments, NBD-phallacidin binding reached a plateau in less than 30 minutes with occasional gentle shaking. Fixation for up to 24 hours did not change the extent and distribution of phallacidin fluorescence. Permeabilization was not necessary, as was also shown to be true of much larger cells, neutrophils, probably because of the small molecular size of NBD-phallacidin (around 800 d).17." In some experiments, NBD-phallacidin was preincubated with rabbit skeletal G-actin or F-actin (2 mg/mL), prepared as de~cribed,'~ before the addition to platelet suspensions in G-buffer (5 mmol/L Tris, pH 7.4, 1 mmol/L GTP) or in F-buffer (100 mmol/L KCl, 1 mmol/L MgCI,), respectively, at a final NBD-phallacidin concentration of 3.3 pmol/L.
After incubation, platelets were washed twice and examined with the FacStar Plus flow cytometer (Becton Dickinson, Braintree, MA). Both NBD and PE were excited with a 5 W argon laser at 200 mW power at a wave length of 488 nm. NBD fluorescence was detected using a 530 f 11 nm band pass filter, and PE fluorescence was detected with a 575 f 11 nm band pass filter. The platelet population was defined by light scattering of 488 nm beam (forward and right angle) to gate out contaminating red cells or cell debris from contamination as described." Five thousand platelets were examined in each sample at a rate of less than 1, OOO cells per second. Log-NBD-fluorescence was converted to a linear scale and calibrated by green standard beads as de~cribed.'~ Aliquots of the platelet samples were pretreated with unlabeled phallacidin (33 pmol/L, 10 times excess of the final concentration of NBDphallacidin) for 1 hour before the addition of NBD-phallacidin. We assumed the mean fluorescence of these pretreated platelets to be a measure of mean nonspecific binding of NBD-phallacidin plus mean autofluorescence. We subtracted this mean fluorescence from the mean fluorescence of counterparts without pretreatment with nonfluorescent phallacidin to estimate the specific mean fluorescence of NBD-phallacidin bound to platelets. 
RESULTS
Because NBD-phallacidin has not previously been used for platelet studies, particular attention was paid to determination of the specificity of NBD-phallacidin to fixed platelets. Platelets in PRP instead of gel-filtered platelets were used, because Fox et a1 reported that gel-filtered platelets with a minimal amount of F-actin can be obtained only in the presence of prostacyclin, a potent platelet inhibitor,".= at 37"C'32; such platelets are not suitable for subsequent stimulation. Spangenberg and Till also described difficulty in the preparation of gel-filtered or washed platelets with a minimal amount of F-actin.6 Fixed resting platelets exposed to NBD-phallacidin (3.3 Fmol/L) increased NBD-fluorescence (excitation 488 nm, emission 530 nm) (Fig lA) , although there was significant overlap between the autofluorescence level and the fluorescence level of NBDphallacidin-treated cells. The increase was not affected by pretreatment of NBD-phallacidin with rabbit G-actin (Fig  lB) , but was markedly inhibited by pretreatment of the fluorescent probe with rabbit F-actin ( Fig 1C) . Pretreatment of platelets by unconjugated phallacidin also largely eliminated the binding of NBD-phallacidin ( Fig 1D) . Taken Fig 2C) for 15 seconds, they had increased phallacidin binding. After either ADP-or U46119-induced stimulation, there were platelets that apparently failed to increase their F-actin content. These platelets constituted a shoulder on the left side of the curve, while the main population, which showed a log normal distribution, shifted to the right. There was significant overlap of the main population and the cells refractory to stimuli, especially in the resting state. When anti-GPIb monoclonal antibody (MoAb; AF'1, the kind gift of Dr Thomas J. Kunicki, South East Wisconsin Blood Center, Milwaukee, WI) and PEconjugated antimouse antibody were used to identify the NBD-phallacidin-pretreated platelet population, their patterns of distribution of NBD-fluorescence were unchanged, indicating that the "shoulder population" was indeed composed of platelets. When platelets were pretreated with cytochalasin D (10 pmol/L) for 1 minute, they did not increase their phallacidin binding with either ADP or U46619 (Fig 2B and D) .
We also examined light scattering by the platelet population, which, when aggregation is inhibited, is considered to be a function of platelet size and ~h a p e . '~,~~*~* *~ In the resting state, glutaraldehyde-fixed platelets had a triangular light scattering distribution in the contour gTaph of their log forward and right angle scattering of a 488 nm beam ( Fig  2E, left panel) , which is consistent with the report of Holme et Within 15 seconds after stimulation by ADP (10 pmol/L) or U46619 (1 pmol/L), the platelet population increased their forward scattering, and at the same time forward scattering and right angle scattering became more linearly correlated than in the resting state (Fig 2E, middle and right panels). When NBD-phallacidin fluorescence was compared with forward scattering (Fig 2F) and right angle scattering (Fig 2G) , it became clear that cells with the least phallacidin binding were the cells with the least forward and right angle light scattering, especially after stimulation with ADP or U46619.
The effects of various stimuli on actin polymerization were examined. As stated above, U46619, ADP, and collagen, which are known to induce shape change,= increased phallacidin binding (Table 1) . Epinephrine, which does not induce shape change in aspirin-treated platelets (ie, during the primary phase of epinephrine-induced platelet activation),= did not increase phallacidin binding Times increased over resting 2 standard deviation. The significance of the increase over resting levels was tested by paired t-test.
*Collagen-induced shape change was delayed in the presence of 5 mmol/L EDTA. Samples were taken approximately 1.5 minutes after the addition of collagen, when the decrease of light transmittance reached its maximal level, as detected by aggregometry.
( Table 1 ). However, cold treatment (4°C for 10 minutes), which is a known stimulant of platelet shape change and actin polymerization,1~2 induced a 1.3-fold increase in mean phallacidin binding to platelets.
ADP-induced actin polymerization, as indicated by phallacidin binding, reached a peak within 15 seconds and then decreased continuously from 1 minute after stimulation; the effects of U46619 were more prolonged than those of ADP (Fig 3) . Figure 4A shows the dose dependency of ADP-induced phallacidin binding from 0.1 to 10 Fmol/L, the concentration range in which ADP induced dosedependent shape change (Fig 4B) .22323,30
It was possible by flow cytometry to measure [Ca'+], in diluted PRP, without gel-filtration or further centrifugation that might cause refractoriness to ADP.31 After the addition of ADP (10 pmol/L) in the presence of extracellular calcium (1 mmol/L), all the platelets elevated their [Ca'+], (Fig 5A) . The removal of extracellular calcium by 5 mmol/L EDTA attenuated the elevation of [Ca"], induced by ADP (Fig 5B) . However, ADP concentrations of 0.5 Fmol/L or more increased [Ca'+], even in the absence of extracellular calcium (Fig 5B and C) , albeit transiently. This finding is consistent with our previous observation^,'^ but is in con- (Fig 5D) . Thus, ADP concentration required to increase [Ca2+], was similar to that necessary for actin polymerization.
U46619 but not ADP is known to induce granule secretion in the absence of extracellular calcium; ADP-induced secretion requires aggregation and secondary thromboxane/ endoperoxide production?' We compared the extent of a-granule release (indicated by binding of S12 MoAb to platelets) with actin polymerization. After stimulation with an agonist, platelets were fixed and exposed to S12 MoAb (20 pg/mL) and, after washing, to PE-conjugated antimouse antibody (goat, 30 pg/mL) and NBD-phallacidin and were then analyzed by flow cytometry. Figure 6 shows a two-color analysis of PE and NBD-fluorescence. Fifteen seconds after the addition of U46619, an increase in NBD-phallacidin fluorescence from the level at 0 seconds is indicated as a rightward shift (compare Fig 6A with 6B ) of the population with the maximal phallacidin binding (the population, shown in Figs 1 and 2C , that had a bell shaped NBD-fluorescence distribution). There is also a small increase in S12 binding, implying a-granule secretion, which is progressively more prominent from 15 seconds through 5 minutes after stimulation (Fig 6C and D) . At 5 minutes after stimulation, the cells that bound the most S12 were the ones that bound the most phallacidin. The proportion of S12-negative cells was higher in the population with the least phallacidin binding, especially in the early stages of platelet stimulation.
DISCUSSION
Heterogeneity in the amount of F-actin in platelets has not been described previously. Measurement of F-actin content by phallacidin binding suggests the presence of heterogeneities in the state of actin polymerization in both resting and stimulated platelets (Figs 1 and 2) . Distribution of autofluorescence level (Fig 1, shown by dotted lines) or autofluorescence plus nonspecific binding (the fluorescence of phallacidin-pretreated cells, Fig 1D) showed a log normal pattern. However, the pattern of distribution of NBD-phallacidin was clearly asymmetrical in both resting and stimulated cells (Figs 1A and 2A and C), and had a leftward shoulder with minimal NBD-phallacidin binding. NBD-phallacidin binding was specific in that it was inhibited by exogenous F-actin but not G-actin (Fig 1B and C) , and the heterogeneity in NBD-phallacidin binding appeared to be due to differences in the degree of specific NBD-phallacidin binding to individual platelets, which, in turn, most likely reflected heterogeneous F-actin content among individual platelets. Inadequate exposure to NBD phallacidin, an alternative possibility as a cause of the heterogeneity, is unlikely, because stimulated platelets showed a clear increase of NBD-phallacidin binding in a majority of platelets. Such heterogeneity was also previously described for neutrophils'721s and may be a general feature of blood cells.
Most of the current knowledge of actin polymerization has been obtained from changes in F-and G-actin content, measured biochemically (by DNAse 1 inhibition or by high speed centrifugation) after the lysis of platelets in EDTA or EGTA containing buffers'3239 to minimize the concentration of ionized calcium; without a calcium chelator, F-actin may be rapidly depolymerized. Although the occurrence of increased actin polymerization was also observed by electron microscopic studies,',' the circumstances have been somewhat puzzling, because, as shown by Fig 5 and reported by actin polymerization occurs at the same time as calcium mobilization. The situation has been termed the "Ca'+ paradox."' It was suggested that gelsolin and calcium elevation, both of which stabilize profilactin complexes in vitro and together sever actin filaments,% may account for the apparent paradox.' If so, depolymerization instead of polymerization of actin could occur in platelets with an elevation of [Ca'+Ii, at least theoretically, because platelet cytoplasm also contains gelsolin and profilin.19 More recent studies suggest that there is no 1:1 stoichiometry between profilin and actin in platelet cytoplasm35 and that these provide no quantitative evidence that EGTA-or EDTA-lysis buffers actually "freeze" the actin strand as it is found within the cells. The results of our studies are consistent with those previously obtained by biochemical techniques.',' We found that U46619, ADP, and collagen increased mean phallacidin binding 1.5 to 1.9 times over the resting levels. Biochemical techniques indicate that F-actin constitutes 30% to 50% of total actin in resting platelets, and it increases to 60% to 80% of the total after stimulation'.'; these values are similar to those detected by our measurement of NBD-phallacidin binding. The effects of cold treatment and of cytochalasin D, examined by flow cytometry, were also consistent with the results of studies performed with biochemical technique^.^^^^^^^^ Thus, there must be mechanisms in vivo that dissociate profilactin in spite of the presence of elevation of ionized calcium concentration and gelsolin, permitting freed G-actin to polymerize.
Our data also confirm the previously described relation of actin polymerization to shape change. Dose-dependent ADP-induced "shape change," verified by light transmission in aggregometry,= was observed (Fig 4B) at ADP concentrations that agreed with previous rep~rts.''~~~'~ U46619, collagen, ADP, and cold treatment, all of which induce "shape change,"= polymerized actin (Table 1) . Epinephrine, which does not cause "shape change," did not increase F-actin (Table 1) . Feinberg et a1 reported a good agreement between actin polymerization and "shape change" in stored platelets.' A causal relation between shape change and actin polymerization is likely; the phosphorylation of myosin light chain may also play a role. '3 We found that ADP-induced actin polymerization was largely reversible, while U46619 induced a more prolonged actin polymerization (Fig 3) . U46619 (1 kmol/L) is in general a more potent stimulus for platelets than ADP, with respect to functions such as granule secretion (Fig 6) . In neutrophils, too, it has been reported that stronger stimuli induced more prolonged actin polymeri~ation."~'~ Other examples of platelet heterogeneity have been documented by flow cytometry,"-I6 but the origin of the heterogeneity has not been clarified. We found a correlation of granule secretion with the degree of specific phallacidin binding (Fig 6) , consistent with our view that many aspects of platelet heterogeneity may be interrelated. 13 Further, we found that the population with the least phallacidin binding was found among the cells with the least forward and right angle light scattering (Fig 2F and G least fibrinogen binding were the cells with the least forward ~cattering.'~ They interpreted forward scattering as an indicator of platelet size and found a linear relation between the amount of GPIIb-IIIa on the platelet surface and forward ~c a t t e r i n g . '~~~
Holme et a1 observed a positive correlation between platelet size estimated by Coulter counter and forward and right angle light ~cattering.'~ Thus, it is possible that the platelets with the least forward and right angle scattering are indeed the smallest platelets. However, we found that light scattering changed within 15 seconds of platelet activation by ADP and U46619, so that in experiments in which aggregation was inhibited by EDTA (5 mmol/L), there was an increase in forward scattering (Fig 2E) . Right angle scattering and forward scattering became more linearly related than in the resting state with either ADP or U46619. These changes are also consistent with the report of Holme et alZ9 and probably are related to platelet "shape change," although it is not clear what aspects of a change in shape are reflected in the scattering of light. They do not appear to be a simple function of platelet size.
In any event, the heterogeneity in F-actin content is not use only. 
